Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Q: What is the clinical evidence from this study?

Study design: Review. Population: Non-ST-elevation acute coronary syndrome (NSTE-ACS). Intervention: Antithrombotic therapy and revascularization strategies.

Emanuele Barbato; Julinda Mehilli; Dirk Sibbing; George C.M. Siontis; Jean‐Philippe Collet; Hölger Thiele; Adnan Kastrati; Mamas A. Mamas; Stephan Windecker

doi:10.1093/eurheartj/ehaa601

July 15, 2020European Heart Journal

Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

View at Publisher

Ask AI

Bookmark

Share

Key Points

To provide evidence-based clinical guidance on antithrombotic regimens and invasive revascularization decision-making for patients presenting with non-ST-elevation acute coronary syndrome.
Case-based clinical consensus companion document translating the 2020 European Society of Cardiology guidelines into practical management scenarios.
Evaluated antithrombotic choices, timing of coronary angiography, dual antiplatelet therapy duration, and bleeding risk stratification tools.
Routine pre-treatment with P2Y12 receptor inhibitors prior to defining coronary anatomy is discouraged when an immediate invasive strategy is planned, with prasugrel preferred over ticagrelor during percutaneous coronary intervention based on clinical trial evidence.
Unfractionated heparin remains the standard peri-interventional parenteral anticoagulant, while routine continuation of parenteral anticoagulation after successful intervention is not recommended.
Dual antiplatelet therapy duration should be customized according to baseline bleeding and thrombotic risks, permitting de-escalation or early discontinuation in high bleeding risk populations.

Structured PICO

P

Population

Patients presenting with non-ST-elevation acute coronary syndrome (NSTE-ACS)

I

Intervention

Antithrombotic therapy (including P2Y12 inhibitors, GP IIb/IIIa antagonists, anticoagulants) and revascularization strategies (PCI)

This companion document provides practical, case-based answers to common clinical questions regarding antithrombotic management and revascularization in NSTE-ACS based on the 2020 ESC Guidelines.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Aids real-world NSTE-ACS antithrombotic and revascularization decisions; extends 2020 ESC Guidelines with case-based practical insights.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Barbato et al. (2020) conducted a review in Non-ST-elevation acute coronary syndrome (NSTE-ACS). Antithrombotic therapy and revascularization strategies was evaluated. This companion document to the 2020 ESC Guidelines provides case-based questions and answers on antithrombotic therapy and revascularization strategies for patients with NSTE-ACS.

synapsesocial.com/papers/6a8c171a90fae8fd47e9a9b4 https://doi.org/10.1093/eurheartj/ehaa601

View at Publisher

Ask AI

Bookmark

Share

Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Key Points

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Key Points

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading